Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose is to evaluate the safety and efficacy of recombinant humanized anti-IgE
monoclonal antibody injection in patients with allergic asthma.